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Introduction: The literature on thromboangiitis obliterans (TAO, Buerger's disease) suffers from the lack of a unified 
method of establishing the diagnosis of the disease. The aim of this study was to test he application ofa point scoring system 
(PSS) in the diagnosis of TAO. 
Method: Points are awarded for young age at onset, foot claudication, upper extremity involvement, superficial vein 
thrombosis and vasospastic phenomena. Atypical features detract points, and the resultant score classifies the diagnosis of 
TAO as being of low, medium or high probability. One hundred and seven patients diagnosed and classified according to 
our previous accepted criteria for TAO, were independently reclassified by the PSS, and the results of the two diagnostic 
processes were compared. 
Results: Of the 107 patients diagnosed by our old criteria (OC) the diagnosis of TAO was rejected by the PSS in 20 
patients. Of the remaining 87 patients the degree of certainty in the diagnosis (PSS vs. OC) was lower in 31 equal in 47 
and higher only in nine. 
Conclusion" The proposed PSS is more discriminating than our OC. If this type of scoring system can be agreed upon the 
certainty in the diagnosis of TAO would be increased. Data collection would be improved, and the cause of clinical and basic 
research would be advanced. 
Introduction 
Clear diagnostic criteria re a minimal requirement for 
defining a disease ntit~4 so that clinical and research 
efforts can be focused on a well defined group of 
patients. In this regard, thromboangiitis obliterans 
(TAO, Buerger's disease) has caused problems ever 
since the earliest descriptions of the disease. 
During the 1960s when the mere existence of TAO 
was questioned L2 a concerted effort was made to 
define the disease and prove its unique nature. 
However a study of a recent comprehensive t xt on 
Buerger's disease, 3 as well as a persusal of the 
appropriate chapter in a current reference textbook in 
vascular surgerN 4 reveals that in spite of a great 
number of publications, there are still no universally 
accepted and standardised iagnostic criteria, for 
defining TAO. 5 
The definition of TAO varies so much between 
different groups of researchers, that it is almost 
impossible to pool or compare the results of basic or 
clinical research. Thus any possible advance in clinical 
management could be frustrated by the lack of a well 
defined set of patients. This study therefore proposes a
method of defining diagnostic riteria for TAO, and 
compares the use of the proposed method, with our 
previous diagnostic method in a group of 107 
patients. 
Materials and Methods 
On the basis of extensive literature research s and our 
own clinical experience, we devised a point scoring 
system that is composed of positive and negative 
points, and is based mainly on clinical findings. 
The diagnosis of TAO is considered in a young 
patient with extremity ischaemia, after ruling out the 
following: Arteriosclerosis obliterans, hypertension, 
diabetes, hyperlipidaemia, a proximal source of embo- 
lism, trauma, collagen disease and hematological 
disorders associated with hypercoagulability. 
Positive points 
Points are awarded for clinical findings that are typical 
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Table 1. Suggested scoring system for the diagnosis of TAO 
A. Positive points 
Age at onset 
Foot IC 
Upper extremity 
Migrating SVT 
Raynaud CC 
Angiography; Biopsy 
Less than 30/3040 years +2/+1 
Present/by history +2/+1 
Symptomatic/Asymptomatic +2 /+1 
Present/by history only +2/+1 
Present/by history only +2/+1 
If typical (see text), both/either +2 /+1 
B. Negative points 
Age at onset 45-50/more than 50 years -1/-2 
Sex, Smoking Female / Non-smoker -1 / -2 
Location Single limb/No LE involved -1/-2 
Absent pu lses  Brachial/Femoral -1/-2 
ASO, DM, FIT, HL Discovered after diagnosis 
5.1-10 years/2.1-5 years later -1/-2 
IC; Intermittent claudication; SVT: Superficial vein thrombosis; 
CC: Colour changes; LE: Lower extremity; ASO: Arteriosclerosis 
obliterans; DM: Diabetes mellitus; HT: Hypertension; 
HL: HyperlJpidaemia. 
and frequent in patients with TAO. There are five 
clinical elements that contribute to a positive score 
(Table 1A): 
(1) Early age at onset, (2) Upper extremity involve- 
ment (UEI): If clinically overt ischaemia is present in 
the hand 2 points are awarded. For asymptomatic 
absence of a pulse or a positive Allen test only I point 
is given, (3) Foot intermittent claudication (FIC), (4) 
Superficial vein thrombosis (SVT) and (5) Raynaud- 
like colour changes (RCC). 
For any of these latter three that are definitely 
present at the time of the study, or very well 
documented in the past, 2 points are awarded. If 
identified by history only, 1 point is given. 
If available, aortography will contribute 1 point if 
the location and pattern of the occlusive lesions and 
the collaterals are typical, 6'7 and if there is no evidence 
of arteriosclerosis. 
One point can also be added in those patients who 
have had histopathological examination of a vascular 
lesion. We propose however that only a thrombus 
with an acute or subacute cellular infiltrate will count 
for this purpose. 8 Without the typical cellular infil- 
trate, non-specific thrombosis, or chronic obliteration 
of a vessel that are often taken as "consistent with" 
TAO will not add any points. 
Table 2. Summary of points defines the probability of the 
diagnosis of TAO 
Number of points Probability of diagnosis 
0-1 Diagnosis excluded 
2-3 Suspected, low probability 
4-5 Probable, medium probability 
6 or more Definite, high probability 
mia, also make TAO less likely, as do absent brachial 
or femoral pulses (Table 1B). 
If a patient with TAO develops arteriosclerosis 
obliterans (ASO), diabetes mellitus (DM), hyper- 
tension (HT) or hyperlipidaemia (HL) within 2-10 
years of the diagnosis of TAO, the necessary re- 
evaluation of the initial diagnosis is also expressed by 
negative points (Table 1B). 
Scoring is completed after all points have been 
assigned. The probability of the diagnosis of Buerger's 
disease is obtained from the arithmetic sum of the 
points (Table 2): Patients can be grouped and reported 
according to low, medium or high probability (2-3, 
4-5, 6 or more points respectively), or any specific 
attribute can be plotted against he individual score 
for each patient. 
Old criteria 
Previous to the use of this suggested scoring system, 
our criteria for diagnosing Buerger's disease were as 
described previously. 9'1° Briefly, the patient was 
labelled suspected TAO (low probability) if he was a 
young male smoker with extremity ischaemia and 
with no evidence of ASO, hyperlipidaemia, diabetes, 
collagen disease, haematological disorder or a poten- 
tial source of proximal emboli. If any one of the three 
recognised hallmarks of the disease (SVT, UEI or RCC) 
was present or could be elicited in the patient's 
history, the diagnosis of Buerger's disease was con- 
sidered probable (medium probability). If two or more 
of the above were present the diagnosis was con- 
sidered definite (high probability). A comparison of 
the old criteria to the new scoring system is given in 
Table 3. 
Negative points 
Points are deducted for onset after age 45, and for 
female sex, and non-smoking. Single limb involve- 
ment especially the absence of lower extremity ischae- 
Patients 
During a thirteen and a half year period (1981-1994) 
107 patients were diagnosed as suffering from TAO at 
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Table 3. Comparison between old criteria, and new scoring system 
Criteria Old New 
1) Female sex and Excluded May be included, 
and non-smokers negative points 
2) Age "Young" no 
accurate limit 
3) UEI Yes/No 
4) SVT, RCC Yes/No 
5) Foot IC 
6) Angiography and/or -- 
histology 
7) ASO, DM, HT, HL Exclusion criteria 
Points by defined 
age groups 
Points by severity 
Points by degree 
of documentation 
Important hallmark 
Points if quite 
typical 
Negative points 
depending on time 
sequence 
UEI: Upper extremity involvement; SVT: Superficial vein thrombosis; 
RCC: Raynaud-like colour changes; IC: Intermittent claudication; 
ASO: Arteriosclerosis obliterans; DM: Diabetes mellitus; 
HT: Hypertension; HL: Hyperlipidaemia. 
Table 4. Reclassification of patients previously diagnosed, 
according to the new scoring system 
By scoring system 
Diagnosis by No. of 
old criteria patients Excl LP MP HP 
Suspected 23 15 5 3 0 
Probable 38 3 13 16 6 
Definite 46 2 2 16 26 
Total 107 20 20 35 32 
1) Exch Diagnosis excluded; LP: Low probability; MP: Medium 
probability; HP: High probability. 
2) Bold figures represent the numbers of patients whose 
classification did not change. 
the Sheba Medical Center. The diagnosis was made on 
the basis of our old criteria. 
These 107 patients were reclassified according to the 
new scoring system, by reviewing the medical charts 
again. This review was carried out independentls~ at a 
later date than the original classification. 
Results 
Table 4 describes the changes that occurred in the 
classification of these patients using the new point 
scoring system. It is evident hat the point system is 
more demanding, as it downgrades the degree of 
certainty of the diagnosis in almost half the patients, 
(51 of 107), while upgrading it in only nine of the 107 
patients. Less than half the patients (47 of 107) 
retained their previous classification. No less than 20 
patients who were previously diagnosed as TAO, were 
excluded by the new point system. 
Downgrading resulted from the negative points 
mainly related to single limb involvement, or absence 
of lower extremity involvement. Conversely the addi- 
tion of points for young age at onset and for FIC - -  
two elements not present in the "old criteria", caused 
upgrading in a few cases. 
The points awarded for typical aortography or 
histopathology, had little effect in this series mainly 
because they were infrequently performed. 
Discussion 
Thromboangiitis obliterans (TAO) continues to be an 
aetiologic dilemma. It is an occlusive vascular disease 
that occurs almost exclusively in young males and 
affects the arms as well as the legs. It occurs almost 
solely in tobacco smokers and demonstrates an inti- 
mate relationship of remission and relapse to cessation 
or resumption of smoking. There is considerable 
geographic variation in the prevalence of the disease, 
and it is more common in some ethnic groups than in 
others. 5,9 
The pathologic changes in TAO consist of an 
inflammatory reaction in the wall of medium- and 
small-sized arteries, sometimes extending to the vein 
and nerve within the neurovascular bundle. There is a 
vasculitis of the vasa vasorum in the wall of the artery, 
with intense infiltration of lymphocytes. This vasculi- 
tis affects the extremities most frequently but has also 
been described in visceral vessels. 
A specific disease state can be identified in one of 
three ways: (1) By demonstrating the presence of the 
known aetiologic agent, such as specific bacteria in the 
infectious disease that is caused by them, (2) By 
eliciting one or more pathologic hanges (by histolog~ 
imaging or other means) that are absolutely pathogno- 
monic of the disease or (3) By identifying the typical 
combination of clinical signs and symptoms of the 
disease, possibly with other supportive evidence. 
When signs and symptoms as well as laboratory or 
X-ray data contribute to a diagnosis, a probabihstic 
approach to the diagnosis is helpful. 
In the case of TAO the aetiology is unknown. The 
specific histopathological evidence of the disease is 
very rarely available in patients that we are called on 
to treat. The angiographic features considered by 
some investigators as pathognomonic are insufficient: 
angiography is not always indicated, and even when it 
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is performed its sensitivity and specificity are not high 
enough to be considered a diagnostic ertainty. In 
most patients, therefore, the diagnosis is made on the 
basis of clinical data. Many of the clinical signs and 
symptoms however are common to other vascular 
ischaemic diseases. This has led to an exasperating 
state of affairs with each investigator choosing a 
different set of criteria, s'n The resultant lack of 
standardisation has negative implications on the 
progress of TAO research. 
Point scoring systems are being popularised in 
several areas in medicine in order to encourage 
systematic ollection of data, and enable groups of 
patients to be better defined and classified. Point 
scoring systems are also suited for defining the degree 
of certainty of a diagnosis, when the diagnosis has to 
be made from a combination of several pieces of 
evidence. 
The idea of using a numerical scale to diagnose TAO 
is not new. Several such scoring systems were pro- 
posed in the late 1960s and early 1970s, 12"q4 based on 
the existing knowledge and prevailing beliefs at the 
time. A low score excluded the diagnosis, ~2 while one 
of the scales also included a stratification of patients, 
according to the probability of a diagnosis of TAO. 14 
These scales differed from each other, and were never 
adopted universally. It is obvious that in order to 
achieve the aims of the system, agreement and general 
acceptance are of the essence. The present scoring 
system is based on an up to date extensive review of 
the literature and a large clinical experience. 
Most series of patients et the age limit for TAO at 
40 to 50 years of age 15'16 but some have no limit at 
all. ~7'~8 In our series the average age of onset of the 
disease was around 30 years. The older the patient, the 
more doubts arise as to the diagnosis, and we 
therefore incorporated age stratification i to our scor- 
ing system. It also incorporates changes in our 
understanding of the disease gleaned from long 
experience, and from recent contributions of other 
experienced clinicians and research workers in the 
field of TAO. In our old criteria there were three 
hallmarks: SVT, UEI and RCC. Over the years we have 
noted that intermittent claudication caused by pain in 
the foot on walking, was a very common element in 
the history of patients with TAO. This has also been 
described by other investigators in the field, 19 and has 
caused FIC to be included in the scoring system. 
Female sex and non-smoking were exclusion criteria 
in many earlier series as well as in our own old 
criteria. However in our experience, as well as others, 
the occasional woman or non-smoking patient have a 
disease that is indistinguishable from TAO. We there- 
fore now consider these two attributes as atypical 
(negative points) but not as exclusion criteria. ASO, 
DM, HT and HL were also exclusion criteria in our 
earlier series. We have however seen many patients on 
long follow-up that appeared to have "pure" TAO 
when they were young but developed one or more of 
these conditions as the years went by. Because we 
believe that there are no aetiological ties between TAO 
on the one hand and ASO, DM, HT and HL on the 
other, we no longer exclude patients with these 
conditions provided that they are not present at the 
time of the initial diagnosis of TAO, or within the first 
2 years of its onset. After that there is a negative score 
that decreases with the passage of time. After 10 years 
the appearance of one of the above mentioned 
diseases does not affect he diagnosis of TAO. 
We have shown that our scoring system affects the 
diagnosis, and that it is more strict than our older 
criteria. It is not possible to make a statistical compar- 
ison because the new PSS is a result of a change of 
emphasis, as well as incorporation of more items of 
data. Most importantly there is no "gold standard" 
test against which this or any other score can be 
independently validated. Until an easily applicable 
diagnostic test can be developed, the PSS offers a more 
disciplined means of making the diagnosis of TAO. 
Because of the design of the study it is not possible 
to state whether the new system would have enabled 
inclusion of some patients that were excluded by the 
old criteria. This could have theoretically applied, for 
instance, to female patients or to non-smokers that 
were excluded by the old criteria. However, the 
numbers of these patients would be quite small, and 
would not affect our conclusions. 
There may be some need to improve or refine the 
various elements of the proposed system. A consensus 
mechanism could be used in order to reach agreement 
over the specifics. Agreement and acceptance may be 
more important han any particular detail of the 
system. 
This scoring system with or without further mod- 
ification, if adopted by all clinicians and researchers 
would help provide a morehomogenous, comparable 
patient series. Data collection and recording would 
both be improved and the cause of TAO research 
would be advanced. 
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